TG Therapeutics Inc (TGTX)
Total asset turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 221,047 | 2,785 | 6,689 | 152 | 152 |
| Total assets | US$ in thousands | 329,587 | 193,572 | 379,629 | 625,642 | 163,014 |
| Total asset turnover | 0.67 | 0.01 | 0.02 | 0.00 | 0.00 |
December 31, 2023 calculation
Total asset turnover = Revenue ÷ Total assets
= $221,047K ÷ $329,587K
= 0.67
Total asset turnover is a financial ratio that measures a company's ability to generate revenue relative to its total assets. The ratio indicates how efficiently the company is using its assets to generate sales.
In the case of TG Therapeutics Inc, the total asset turnover has shown significant improvement over the years. From 2019 to 2023, the ratio has increased from almost 0 to 0.67. This suggests that the company is utilizing its assets more effectively to generate revenue.
A low total asset turnover in 2019 and 2020 may indicate inefficient use of assets, possibly due to underutilization or poor asset management. However, the significant improvement in 2021 and further in 2022 and 2023 reflects a positive trend towards more efficient asset utilization.
Overall, the increase in total asset turnover indicates that TG Therapeutics Inc has been able to improve its operational efficiency and generate more revenue relative to its total assets in recent years. This trend is a positive sign of improved asset management and overall financial performance.
Peer comparison
Dec 31, 2023